Home/Filings/4/0000950170-24-038822
4//SEC Filing

TREACE JAMES T 4

Accession 0000950170-24-038822

CIK 0001630627other

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 9:55 PM ET

Size

11.1 KB

Accession

0000950170-24-038822

Insider Transaction Report

Form 4
Period: 2022-11-15
Transactions
  • Sale

    Common Stock

    2022-11-15$21.18/sh1,600$33,8901,038,341 total
  • Sale

    Common Stock

    2022-11-15$21.97/sh200$4,3941,038,141 total
  • Sale

    Common Stock

    2022-11-15$24.02/sh1,700$40,8281,036,441 total
  • Sale

    Common Stock

    2022-11-15$20.12/sh46,500$935,5801,039,941 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    556,183
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.55 to $20.4600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.6200 to $21.5400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.6100 to $24.6000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

TREACE MEDICAL CONCEPTS, INC.

CIK 0001630627

Entity typeother

Related Parties

1
  • filerCIK 0001185191

Filing Metadata

Form type
4
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 9:55 PM ET
Size
11.1 KB